Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

HEMOGLOBIN - ANVISA Registration 81327670105

Access comprehensive regulatory information for HEMOGLOBIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81327670105 and manufactured by ACON LABORATORIES, INC.. The registration is held by DNEDX COMERCIO E SERVICOS PARA PRODUTOS DA SAUDE LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including NOVA BIOMEDICAL CORPORATION, DOLES REAGENTES E EQUIPAMENTOS PARA LABORATORIOS LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
81327670105
Registration Details
ANVISA Registration Number: 81327670105
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Solução Controle de Hemoglobina Hb Mission®
Risk Class II

Registration Details

81327670105

25351074708201966

22940751000120

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

May 20, 2019

VIGENTE

09/18/2025 19:00:01